
Clinical trials are essential in improving treatment in the world of oncology, especially for rare cancers.

Clinical trials are essential in improving treatment in the world of oncology, especially for rare cancers.

Hear patient-to-patient advice on navigating the complicated landscape of cancer care (and its costs).

A patient advocate goes through the three steps of genetic testing.

For years, there has been much debate over whether or not sugar fuels cancer.

For some breast cancer survivors, 3D nipple tattooing is the right choice. Others may turn to body art or choose to do nothing at all.









Despite being diagnosed with cholangiocarcinoma, a cancer of the bile duct, Maria Falzone, a safe sex speaker and comedienne, maintains her sense of humor.

Patients with the disease reported increased feelings of stigmatization, and results also showed that patients are viewed or treated differently than those with other cancer types.

“We’re all really aware now, so what are we doing about it?” Zionna Hanson, founder of Barbells for Boobs, said.

Share your cancer story, says news anchor and survivor Amy Robach.

As more treatment options become availabe in the cancer space, it may be difficult for patients and their caregivers to decide on the best plan of action. Maggie Row, M.D. offers her advice.

While the living rooms take place in the ALCF's California headquarters, people around the world can tune in to the live stream, where they can participate and ask questions as if they were actually there.

Genomics are starting to play a crucial role in treatment planning for patients with essential thrombocythemia.

CURE headed out to Washington, DC to cover the Biden Cancer Summit.

All the wishes granted at Make-A-Wish New Jersey are special, from meet and greets with A-list celebrities, to smaller wishes that are just as meaningful.

Patrick Dempsey discusses National Ovarian Cancer Awareness Month.

One oncology nurse developed the BARF scale so her young patients could better communicate how they were feeling.

A certain group of patients may not be candidates for common therapies, explained Bijal D. Shah, M.D.




